BU BURCON NUTRASCIENCE CORPORATION

Burcon Achieves Record Production, Expands to More than 20 Buying Customers and Evaluates Additional Capacity Expansion

Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based proteins, today announced recent operational and commercial milestones demonstrating accelerating momentum in its scale-up and commercialization strategy.

Over the past several weeks, the Company achieved record production, increasing average daily output by approximately 40% as compared to the calendar Q1 average, which proves production capability needed to achieve 2026 goals. In response to growing demand, Burcon and its manufacturing partner, RE ProMan LLC, are evaluating additional capacity expansion opportunities to support future customer requirements.

Burcon has expanded its commercial footprint to more than 20 buying customers across multiple food and beverage categories, including ready-to-mix beverages, nutrition products and plant-based food applications, reflecting growing market adoption of its protein ingredients.

Demand is being generated across Burcon's full product portfolio, including Peazzaz®, FavaProTM and Puratein®, which are designed to deliver high purity, functionality, taste and solubility across a broad range of applications.

"We are encouraged by the continued progress across both our operations and commercial activities," said Kip Underwood, Chief Executive Officer. "Increased record production levels, a growing base of buying customers and continued capacity expansion efforts reflect a business gaining traction in the market. Our focus remains on scaling efficiently, supporting customer growth and executing against our path to profitability."

Food manufacturers seeking high-performance plant-based protein solutions are encouraged to contact the Company to discuss product evaluation opportunities.

About Burcon NutraScience Corporation

Burcon is a global technology leader in plant-based proteins for food and beverage applications. The Company has developed a portfolio of high-performance protein ingredients, including Peazzaz®, FavaProTM and Puratein®, and is focused on commercializing its technologies through manufacturing partnerships and growing customer adoption worldwide.

Forward-Looking Information Cautionary Statement
The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation, including statements relating to insider participation in the private placement. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as "anticipate," "aim", "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," "should," "could," "will" and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations, and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form for the year ended March 31, 2025 and its other public filings with Canadian securities regulators on SEDAR+ at . This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.

Industry and Investor Contact
Investor Relations and Communications
Burcon NutraScience Corporation
490 - 999 West Broadway, Vancouver, BC, V5Z 1K5
Tel (604) 733-0896

Media Contact:
Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267

To view the source version of this press release, please visit

EN
20/04/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on BURCON NUTRASCIENCE CORPORATION

 PRESS RELEASE

Burcon Achieves Record Production, Expands to More than 20 Buying Cust...

Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based proteins, today announced recent operational and commercial milestones demonstrating accelerating momentum in its scale-up and commercialization strategy.Over the past several weeks, the Company achieved record production, increasing average daily output by approximately 40% as compared to the calendar Q1 average, which proves production capability needed to achieve 2026 goals. In response to growing dem...

 PRESS RELEASE

Burcon Closes Second Tranche of Non-Brokered Private Placement of Conv...

Vancouver, British Columbia--(Newsfile Corp. - February 27, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce the closing of the second tranche of its previously announced non-brokered private placement (see news releases of the Company dated January 2, 2026 and January 9, 2026) of convertible debentures (the "Convertible Debentures") for an aggregate principal amount of $6.9 million (the "Private Placement"). Under the second tranche, Burcon issued Convertible Deben...

 PRESS RELEASE

Burcon Announces Results of Shareholder Meeting

Vancouver, British Columbia--(Newsfile Corp. - February 20, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (the "Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce that all meeting matters put forth to shareholders, as voted on by shareholders, and where applicable, disinterested shareholders, were duly approved at its 2026 special meeting of shareholders (the "Meeting") held on February 20, 2026. Shareholders of the Company approved the resolutions related to the Company's private placement of convertible debentur...

 PRESS RELEASE

Burcon Announces Fiscal 2026 Third Quarter Results

Strong Q3 Revenue Growth Driven by Expanding Commercial TractionVancouver, British Columbia--(Newsfile Corp. - February 11, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, reported results for the fiscal third quarter ended December 31, 2025."Fiscal Q3 marked an important milestone in Burcon's commercial growth," said Kip Underwood, Burcon's chief executive officer. "We ramped production, fulfilled recurring customer orders, and strengthened key customer relationships, building momentum ...

 PRESS RELEASE

Burcon Announces Details on Special Meeting of Shareholders and Amendm...

Vancouver, British Columbia--(Newsfile Corp. - February 4, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, will be holding a special meeting (the "Meeting") of shareholders at 10 am Pacific Time on February 20, 2026 held virtually via live webcast at .Warrant AmendmentBurcon announces that the expiry date of certain outstanding warrants of the Company ("Warrants") is being extended to June 30, 2027. Warrants held by non-insiders will be amended effective February 19, 2026, whereas the am...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch